WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

The investigation centers on whether the Company made false and/or misleading statements or failed to disclose material information relevant to investors. On February 5, 2025, Grizzly Research released a report titled: "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud." The report asserts that the Company's "growth is largely an illusion, driven by fraudulent schemes and illegal tactics" allegedly designed to manipulate Medicaid and Medicare programs to artificially boost revenue. It further claims that "testimonies from former employees and pending litigation indicate GeneDx inflated earnings through the unlawful practice of 'code stacking,'" which "allows billing for services that fail to meet the appropriate standards." The report also alleges that "CEO Katherine Stueland and CFO Kevin Feeley have routinely sold their shares upon vesting, without participating in open market acquisitions," a "pattern suggest[ing] insider awareness of a looming threat likely to affect the business." 

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.